secwatch.observer — SEC 8-K summary
======================================

Issuer:     ClearPoint Neuro, Inc. (CLPT)
CIK:        0001285550
Form:       8-K
Filed at:   2024-11-07T23:59:59+00:00
Accession:  0001285550-24-000120
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ClearPoint Neuro Q3 revenue $8.1M (+41% YoY); FY guidance reaffirmed
--------------------------------------------------------------------

- Record quarterly revenue of $8.1M, up 41% YoY; navigation & device revenue $2.9M (+49%).
- Biologics & drug delivery revenue $4.4M (+27%); capital equipment revenue $0.8M (+133%).
- Gross margin 60% vs 57% YoY; operating expenses $10M (up from $8.2M) on higher personnel and development costs.
- Cash $21.6M; fully repaid $10M convertible note leaving no debt; operational cash burn cut 33% to $1.2M.
- Activated 5 new centers in Q3 (19 YTD, ~3x historic rate); FY 2024 revenue outlook held at $30-33M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1285550/000128555024000120/0001285550-24-000120-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1285550/000128555024000120/clpt-20241107.htm
  HTML page:      https://secwatch.observer/filing/0001285550-24-000120

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer